WeVote
Log In

Bill

Bill

SB 51

An Act exempting veterinarians from the requirements of the controlled substance prescription database; and providing for an effective date.

33rd Legislature (2023-2024) Introduced by Jesse Bjorkman and 8 co-sponsors

SB 51 exempts Alaska veterinarians from reporting controlled substance prescriptions to the state's prescription drug monitoring database, reducing administrative requirements for animal care providers.

(S) Minutes (SL&C)
#animals #business #drugs #health&socialservices #hospitals #licensing #medicalcare #occupations&professions #pharmacists
0
WeVote Research Nonpartisan
Bill Summary · SB 51

Legislative bill overview

SB 51 would exempt veterinarians from Alaska's controlled substance prescription database (PDMP) requirements when prescribing controlled drugs to animals. Currently, veterinarians must report prescriptions through the same monitoring system as human healthcare providers. This bill removes that obligation for veterinary practice.

Why is this important

Veterinarians argue the human-focused PDMP system creates administrative burden without meaningful oversight benefit for animal care, as veterinary controlled substances (primarily pain management and anesthesia) follow different protocols and risks than human pharmaceuticals. Streamlining reporting requirements could reduce compliance costs for veterinary clinics while maintaining state pharmacy board oversight through existing veterinary licensing regulations.

Potential points of contention

  • Drug diversion risk: Removing database tracking could make it harder to detect veterinarians illegally diverting controlled substances for human consumption or illegal distribution, though proponents note veterinary prescriptions represent a small fraction of total controlled substance volume
  • Regulatory consistency: Creating a separate system for veterinarians may conflict with federal controlled substance monitoring initiatives and interstate coordination efforts that assume comprehensive reporting
  • Limited legislative detail: The bill's brevity provides no alternative oversight mechanisms, leaving unclear how diversion will be monitored or what exceptions (if any) might apply for suspicious activity

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.